Institut Curie - site de Paris

Paris, Paris 75005

1 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Recurrent or Metastatic Solid Tumors

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) — Recruiting now
• DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02] — Completed